Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
COVID-19
Influenza
Tick-borne encephalitis
Older adults
2023
2021
Clear all
Type of publications
NITAG documentation
(1)
Systematic reviews (SYSVAC)
(177)
Topics
Available to download in languages
Regions
Africa
(2)
Americas
(1)
Eastern Mediterranean
(1)
Europe
(4)
South-East Asia
(1)
Western Pacific
(3)
Countries
Diseases
COVID-19
(163)
Influenza
(15)
Tick-borne encephalitis
(1)
Diphtheria
(1)
Ebola
(1)
Hepatitis B
(3)
Herpes zoster
(10)
Human papillomavirus (HPV)
(5)
Pertussis
(1)
Pneumococcal disease
(9)
RSV (Respiratory syncytial virus)
(4)
Tetanus
(2)
Vaccine topics
Acceptance
(12)
Administration
(17)
Coverage
(4)
Economic aspects
(2)
Efficacy/effectiveness
(61)
Ethical issues
(5)
Safety
(72)
Target population
Older adults
(178)
Adolescents
(54)
Adults
(202)
All age groups
(209)
Children
(24)
Healthcare workers
(48)
Newborn
(9)
Parents/caregivers
(16)
Pregnant women
(45)
Risk group
(2)
Publication date
2023
(64)
2021
(114)
2024
(1)
2022
(203)
2020
(61)
2019
(10)
2018
(10)
2017
(8)
2016
(7)
2015
(4)
2014
(5)
2013
(3)
2012
(3)
2011
(2)
178 results found
2023
∙
Elhassan, Yasir S. Iqbal, Fizzah Arlt, Wiebke Baldeweg, Stephanie E. Levy, Miles Stewart, Paul M. Wass, John Pavord, Sue Aled Rees, D. Ronchi, Cristina L.
COVID-19-related adrenal haemorrhage: Multicentre UK experience and systematic review of the literature
2023
∙
Wankhede, D. Grover, S. Hofman, P.
Determinants of humoral immune response to SARS-CoV-2 vaccines in solid cancer patients: A systematic review and meta-analysis
2023
∙
Zhang, J. Yang, W. Huang, F. Zhang, K.
Effectiveness of mRNA and viral-vector vaccines in epidemic period led by different SARS-CoV-2 variants: a systematic review and meta-analysis
2023
∙
Hausinger, R. I. Bachmann, Q. Crone-Rawe, T. Hannane, N. Monsef, I. Haller, B. Heemann, U. Skoetz, N. Kreuzberger, N. Schmaderer, C.
Effectiveness, Immunogenicity and Harms of Additional SARS-CoV-2 Vaccine Doses in Kidney Transplant Recipients: A Systematic Review
2023
∙
Law, M. Ho, S. S. H. Tsang, G. K. C. Ho, C. M. Y. Kwan, C. M. Yan, V. K. C. Yiu, H. H. E. Lai, F. T. T. Wong, I. C. K. Chan, E. W. Y.
Efficacy and effectiveness of inactivated vaccines against symptomatic COVID-19, severe COVID-19, and COVID-19 clinical outcomes in the general population: a systematic review and meta-analysis
2023
∙
Joudeh, A. I. Lutf, A. Q. Mahdi, S. Tran, G.
Efficacy and safety of mRNA and AstraZeneca COVID-19 vaccines in patients with autoimmune rheumatic diseases: A systematic review
2023
∙
Wen, J. Liu, Q. Tang, D. He, J. Q.
Efficacy of BCG Vaccination against COVID-19: Systematic Review and Meta-Analysis of Randomized Controlled Trials
2023
∙
Abdelhady, M. Husain, M. A. Hawas, Y. Elazb, M. A. Mansour, L. S. Mohamed, M. Abdelwahab, M. M. Aljabali, A. Negida, A.
Encephalitis following COVID-19 Vaccination: A Systematic Review
2023
∙
Murali, Mayur Gumber, Leher Jethwa, Hannah Ganesh, Divolka Hartmann-Boyce, Jamie Sood, Harpreet Zaccardi, Francesco Khunti, Kamlesh
Ethnic minority representation in UK COVID-19 trials: systematic review and meta-analysis
2023
∙
Tiozzo, Giorgia Louwsma, Timon Konings, Stefan R. A. Vondeling, Gerard T. Perez Gomez, Judith Postma, Maarten J. Freriks, Roel D.
Evaluating the reactogenicity of COVID-19 vaccines from network-meta analyses
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register